Breaking News Instant updates and real-time market news.

DPLO

Diplomat Pharmacy

$19.42

-2.035 (-9.49%)

04:55
08/08/18
08/08
04:55
08/08/18
04:55

Diplomat Pharmacy management to meet with JPMorgan

Meeting to be held in New York on August 8 hosted by JPMorgan.

  • 08

    Aug

  • 13

    Sep

DPLO Diplomat Pharmacy
$19.42

-2.035 (-9.49%)

05/10/18
JPMS
05/10/18
UPGRADE
Target $27
JPMS
Overweight
Diplomat Pharmacy upgraded to Overweight with $27 target at JPMorgan
JPMorgan analyst Lisa Gill upgraded Diplomat Pharmacy to Overweight from Neutral and raised her price target for the shares to $27 from $24. The analyst sees opportunities for the company on the pharmacy benefits manager side of the business and believes Diplomat has the flexibility to pursue accretive acquisitions.
06/22/18
LEER
06/22/18
NO CHANGE
Target $33
LEER
Outperform
Diplomat Pharmacy price target raised to $33 from $27 at Leerink
Leerink analyst David Larsen raised his price target for Diplomat Pharmacy to $33 after hosting investor meetings with management. The analyst believes demand for Diplomat's pharmacy benefits manager CastiaRx is accelerating relative to previous years. Further, he thinks earnings potential from biosimilars, over the long run, may be greater than what he had been expecting. In addition, Larsen is "positively surprised" that the senior leadership team does not view President Trump's Blueprint plan as a significant risk. The analyst reiterates an Outperform rating on Diplomat Pharmacy.
06/28/18
JPMS
06/28/18
NO CHANGE
JPMS
Amazon deal creates significant overhang on Rx channel sentiment, says JPMorgan
JPMorgan Analyst Lisa Gill said Amazon's (AMZN) agreement to acquire PillPack is expected to drive a "significant overhang" on sentiment across the prescription channel, even though she doesn't expect PillPack to capture a material share of the market in the near term. While the deal establishes an initial foothold for Amazon in the mail pharmacy space, she thinks it will take time to scale up and she does not believe PillPack's unit dose packaging technology is unique. Gill also noted that Express Scripts (ESRX) said it would remove PillPack from its pharmacy network in 2016 on allegations it had misrepresented itself as a retail pharmacy and not a mail pharmacy, though within weeks PillPack was added back by the PBM. Shares of retail pharmacy operators CVS Health (CVS), Walgreens (WBA) and Rite Aid (RAD) have all been pressured by the news of Amazon's deal, as have the shares of drug distributors AmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson (MCK). Diplomat Pharmacy (DPLO), an operator of a specialty pharmacy, is also sharply lower following the announcement from Amazon.
07/23/18
WBLR
07/23/18
NO CHANGE
WBLR
Outperform
Diplomat Pharmacy recent selloff overdone, says William Blair
William Blair analyst John Kreger attributes the 20% pullback in shares of Diplomat Pharmacy from the June highs to growing concerns about the company's exposure to pharmaceutical rebates, which the Trump administration is seeking to regulate as part of a broader effort to lower drug prices for consumers. The analyst views the recent selloff as overdone. The vast majority of Diplomat's newly acquired pharmacy benefit management business is with commercial clients, rather than from Medicaid or Medicare Part D, Kreger tells investors in a research note. As such, any new regulations out of the Trump administration would presumably not affect PBM dealings with commercial clients, at least not directly, the analyst adds. Further, the analyst notes that rebates are just one of three broad ways in which PBMs are compensated by their clients. The other two are administrative per-claim fees and spread pricing on dispensed prescriptions. If rebates become less popular, the economics of the business could quickly shift to other payment mechanisms such as higher per-claim fees, Kreger contends. He does not view regulation of drug rebates as a long-term threat to the economics of the PBM business model for Diplomat or its larger peers. The analyst keeps an Outperform rating on Diplomat Pharmacy.

TODAY'S FREE FLY STORIES

JNJ

Johnson & Johnson

$137.77

1.13 (0.83%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Hot Stocks
Janssen submits sBLA for daratumumab combination therapy to FDA »

Janssen Pharmaceutical of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 25

    Apr

WAB

Wabtec

$70.62

0.62 (0.89%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Options
Wabtec put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$17.74

3.87 (27.90%)

, DO

Diamond Offshore

$10.69

0.39 (3.79%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Options
Early notable gainers among liquid option names on March 26th »

Notable gainers among…

BBBY

Bed Bath & Beyond

$17.74

3.87 (27.90%)

DO

Diamond Offshore

$10.69

0.39 (3.79%)

VIAB

Viacom

$27.08

0.75 (2.85%)

RIG

Transocean

$9.27

0.44 (4.98%)

NVDA

Nvidia

$181.50

7.695 (4.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

  • 22

    May

DWDP

DowDuPont

$53.96

0.7 (1.31%)

09:55
03/26/19
03/26
09:55
03/26/19
09:55
Conference/Events
House Science, Space & Technology to hold a hearing »

The Subcommittee on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 28

    May

09:51
03/26/19
03/26
09:51
03/26/19
09:51
Conference/Events
House Financial Services Committee to hold a markup »

The Committee holds a…

09:50
03/26/19
03/26
09:50
03/26/19
09:50
General news
U.S. Richmond Fed index preview: »

U.S. Richmond Fed index…

SQ

Square

$74.65

0.12 (0.16%)

09:49
03/26/19
03/26
09:49
03/26/19
09:49
Recommendations
Square analyst commentary  »

Opposition to Square ILC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,199.98

7.26 (0.61%)

, GOOGL

Alphabet Class A

$1,204.92

7.79 (0.65%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Periodicals
Google's Local Experiments Project looks to bolster community news, Axios says »

Google (GOOG, GOOGL) is…

GOOG

Alphabet

$1,199.98

7.26 (0.61%)

GOOGL

Alphabet Class A

$1,204.92

7.79 (0.65%)

MNI

McClatchy

$5.01

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$41.92

-2.92 (-6.51%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF falls -6.5% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$6.70

-0.44 (-6.16%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Britannia Bulk falls -6.4% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUK

Carnival plc

$51.67

-4.02 (-7.22%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Carnival plc falls -6.6% »

Carnival plc is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

BBW

Build-A-Bear

$5.86

0.22 (3.90%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Build-A-Bear rises 4.1% »

Build-A-Bear is up 4.1%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCO

Universal Compression

$21.55

0.86 (4.16%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
Universal Compression rises 4.2% »

Universal Compression is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$25.64

1.16 (4.74%)

09:47
03/26/19
03/26
09:47
03/26/19
09:47
Hot Stocks
California Resources rises 4.6% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Apr

09:45
03/26/19
03/26
09:45
03/26/19
09:45
General news
U.S. consumer confidence preview: »

U.S. consumer confidence…

09:45
03/26/19
03/26
09:45
03/26/19
09:45
General news
Consumer Confidence to be reported at 10:00 »

March Consumer Confidence…

09:45
03/26/19
03/26
09:45
03/26/19
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

March Richmond Fed…

MDSO

Medidata

$75.89

(0.00%)

09:44
03/26/19
03/26
09:44
03/26/19
09:44
Hot Stocks
Breaking Hot Stocks news story on Medidata »

Medidata mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIB

Bancolombia

$51.71

(0.00%)

09:44
03/26/19
03/26
09:44
03/26/19
09:44
Conference/Events
Bancolombia management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

AGPYY

Agile Group

$0.00

(0.00%)

09:41
03/26/19
03/26
09:41
03/26/19
09:41
Conference/Events
Agile Group management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$82.35

(0.00%)

09:41
03/26/19
03/26
09:41
03/26/19
09:41
Hot Stocks
Avenatti says Nike has been uncooperative with investigators for over a year »

Lawyer Michael Avenatti…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 04

    Apr

ETR

Entergy

$95.84

(0.00%)

, ALDX

Aldeyra

$7.14

(0.00%)

09:40
03/26/19
03/26
09:40
03/26/19
09:40
Options
Unusually active option classes on open March 26th »

Unusual total active…

ETR

Entergy

$95.84

(0.00%)

ALDX

Aldeyra

$7.14

(0.00%)

CCL

Carnival

$56.67

(0.00%)

BBBY

Bed Bath & Beyond

$13.87

(0.00%)

TLT

iShares 20+ Year Treasury Bond Fund

$125.07

(0.00%)

GME

GameStop

$10.14

(0.00%)

NOK

Nokia

$5.87

(0.00%)

RIG

Transocean

$8.83

(0.00%)

XLP

Consumer Staples Sector SPDR

$55.20

(0.00%)

CRON

Cronos Group

$20.50

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 26

    Mar

  • 26

    Mar

  • 02

    Apr

  • 10

    Apr

  • 16

    Apr

  • 20

    May

  • 22

    May

ALXN

Alexion

$132.29

2.29 (1.76%)

09:38
03/26/19
03/26
09:38
03/26/19
09:38
Conference/Events
Alexion participates in a conference call with JPMorgan »

SMid Biotech Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 28

    Jun

SYNA

Synaptics

$32.71

-0.01 (-0.03%)

, DLGNF

Dialog Semiconductor

$0.00

(0.00%)

09:38
03/26/19
03/26
09:38
03/26/19
09:38
Periodicals
Dialog may have 'opportune' chance to revisit Synaptics talks, says Dealreporter »

Dealreporter noted that…

SYNA

Synaptics

$32.71

-0.01 (-0.03%)

DLGNF

Dialog Semiconductor

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

CARG

CarGurus

$38.06

0.31 (0.82%)

09:38
03/26/19
03/26
09:38
03/26/19
09:38
Recommendations
CarGurus analyst commentary  »

CarGurus Buy rating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.